BridgeBio Pharma BBIO Insider Ownership

NASDAQ BBIO

$68.18 +0.63 (+0.93%)

As of: Oct 21, 2026 · 3:06 PM EDT

Insider Holdings by Owner

34.21Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

20.13%

▼-0.408% pp QoQ

Shares Held by Insiders

39.42Mn

filed for Sep 2026

▼-1.99% QoQ

Shares Outstanding

195.79Mn

195,785,884 shares

Direct Holdings

2.07Mn

Indirect: 37.35Mn

Net Shares Traded (QoQ)

-799.38K

net selling in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 11, 2026

Over the trailing 12 months, BBIO insiders sold $118.21 million worth of shares (1.67Mn shares) in open-market trades, with no open-market purchases.

Counted by insider, open-market selling of BBIO stock in the past 12 months came from 10 insiders, with no insider buying.
Neil Kumar (Chief Executive Officer) led open-market sales of BridgeBio Pharma stock over the past 12 months with $57.15 million (805.3K shares), most recently on September 17, 2026.
In transactions other than open-market trades, BridgeBio Pharma insiders received 77.2K shares in stock awards, acquired 820.04K shares through option exercises and conversions and gave up 288.13K shares to cover taxes or exercise prices over the past 12 months.
Business Quant data shows BridgeBio Pharma insiders holding 39.42Mn shares in total in their latest Form 4 filings, or 20.13% of the 195.79Mn shares outstanding; that total is down 1.99% from 40.21Mn shares at the end of Q2 2026 and down 4.62% from 41.32Mn shares at the end of Q3 2025.
Indirect holdings, through trusts, partnerships, family members and other entities, make up 94.76% (37.35Mn shares) of BridgeBio Pharma's insider total, with the other 5.24% (2.07Mn shares) held directly.
The insider holdings in BridgeBio Pharma belong to 19 insiders who have reported on Form 4 within the past two years.
BBIO's three largest insider shareholders, per their latest Form 4 filings, are Viking Global Investors LP (10% owner, 18.56Mn shares), KKR Genetic Disorder L.P. (10% owner, 13.26Mn shares) and Neil Kumar (Chief Executive Officer, 4.31Mn shares).
Viking Global Investors LP alone accounts for 47.08% of the shares held by BridgeBio Pharma insiders.
In the past year, 16 insiders of BridgeBio Pharma submitted 62 Form 4 filings reporting trades, awards or other transactions.
The insider holdings and trades above for BridgeBio Pharma reflect Form 4 filings through September 21, 2026.

Form 4 Holdings

Insiders Holding BBIO

Insiders 21

Shares held 34.21Mn

Of outstanding 17.47%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Global Investors Lp Viking	TenPercentOwner	0	18,555,375	18,555,375	54.2%	01 Jul, 2025
2	Genetic Disorder L.P. Kkr	TenPercentOwner	0	13,260,971	13,260,971	38.8%	14 May, 2025
3	Charles J Homcy	Chairman Of Pharmaceuticals	919,876	0	919,876	2.7%	24 Jun, 2026
4	Neil Kumar	Chief Executive Officer	0	495,686	495,686	1.4%	21 Sep, 2026
5	Thomas Trimarchi	President And Cfo	336,529	0	336,529	1.0%	18 Aug, 2026
6	Ali J. Satvat	Director	169,983	0	169,983	0.5%	24 Jun, 2026
7	Maricel Apuli	Chief Accounting Officer	122,687	0	122,687	0.4%	18 Aug, 2026
8	Brian C Stephenson	Cfo And Treasurer	102,464	0	102,464	0.3%	27 Feb, 2025
9	Richard H Scheller	Director	53,822	0	53,822	0.2%	21 Feb, 2023
10	Fred Hassan	Director	29,879	0	29,879	0.1%	24 Jun, 2026
11	Andrea Ellis	Director	22,579	0	22,579	0.1%	13 Jul, 2026
12	Ronald J Daniels	Director	20,981	0	20,981	0.1%	24 Jun, 2026
13	James C Momtazee	Director	19,070	0	19,070	0.1%	24 Jun, 2026
14	Andrew Lo	Director	18,079	0	18,079	0.1%	24 Jun, 2026
15	Brent L Saunders	Director	17,600	0	17,600	0.1%	03 Jan, 2022
16	Randal W. Scott	Director	11,589	0	11,589	0.0%	19 May, 2026
17	Frank Mccormick	Chairman Of Oncology	10,579	0	10,579	0.0%	24 Jun, 2026
18	Douglas A. Dachille	Director	10,579	0	10,579	0.0%	24 Jun, 2026
19	Eric Aguiar	Director	10,579	0	10,579	0.0%	24 Jun, 2026
20	Hannah Valantine	Director	9,259	0	9,259	0.0%	24 Jun, 2026
21	Jennifer E. Cook	Director	8,383	0	8,383	0.0%	13 Jul, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

1,182 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
17 Sep, 2026	Neil Kumar	Chief Executive Officer	Disposed S	8,721	$69.01	$601.87K	496,965	Indirect
17 Sep, 2026	Neil Kumar	Chief Executive Officer	Disposed S	1,279	$69.57	$88.98K	495,686	Indirect
18 Aug, 2026	Neil Kumar	Chief Executive Officer	Disposed S	1,900	$81.15	$154.18K	276,407	Direct
18 Aug, 2026	Neil Kumar	Chief Executive Officer	Disposed S	17,279	$82.21	$1.42Mn	259,128	Direct
18 Aug, 2026	Neil Kumar	Chief Executive Officer	Disposed S	14,602	$82.99	$1.21Mn	244,526	Direct
18 Aug, 2026	Neil Kumar	Chief Executive Officer	Disposed S	1,199	$83.77	$100.44K	243,327	Direct
19 Aug, 2026	Neil Kumar	Chief Executive Officer	Disposed S	8,100	$83.86	$679.26K	507,586	Indirect
19 Aug, 2026	Neil Kumar	Chief Executive Officer	Disposed S	1,800	$84.69	$152.44K	505,786	Indirect
19 Aug, 2026	Neil Kumar	Chief Executive Officer	Disposed S	100	$85.65	$8.57K	505,686	Indirect
16 Aug, 2026	Neil Kumar	Chief Executive Officer	Acquired M	33,544	—	—	276,871	Direct
16 Aug, 2026	Maricel Apuli	Chief Accounting Officer	Disposed F	4,714	$79.86	$376.46K	122,687	Direct
16 Aug, 2026	Thomas Trimarchi	President And Cfo	Disposed F	22,781	$79.86	$1.82Mn	336,529	Direct
16 Aug, 2026	Neil Kumar	Chief Executive Officer	Acquired M	19,599	—	—	296,470	Direct
16 Aug, 2026	Neil Kumar	Chief Executive Officer	Acquired M	11,554	—	—	308,024	Direct
16 Aug, 2026	Neil Kumar	Chief Executive Officer	Acquired M	6,520	—	—	314,544	Direct
16 Aug, 2026	Neil Kumar	Chief Executive Officer	Disposed F	36,237	$79.86	$2.89Mn	278,307	Direct
16 Aug, 2026	Neil Kumar	Chief Executive Officer	Disposed M	33,544	$0.00	$0	67,088	Direct
16 Aug, 2026	Neil Kumar	Chief Executive Officer	Disposed M	19,599	$0.00	$0	117,596	Direct
16 Aug, 2026	Neil Kumar	Chief Executive Officer	Disposed M	11,554	$0.00	$0	115,538	Direct
16 Aug, 2026	Neil Kumar	Chief Executive Officer	Disposed M	6,520	$0.00	$0	91,274	Direct

Showing 1 to 20 of 1,182 transactions